Publicacions en què col·labora amb María Pilar Alzuguren Maza (14)

2020

  1. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient

    British Journal of Dermatology, Vol. 182, Núm. 5, pp. 1194-1204

2015

  1. Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model

    Gene Therapy, Vol. 22, Núm. 9, pp. 696-706

  2. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver

    Liver International, Vol. 35, Núm. 4, pp. 1274-1289

2013

  1. Target-mediated disposition model describing the dynamics of IL12 and IFNγ after administration of a mifepristone-inducible adenoviral vector for IL-12 expression in mice

    AAPS Journal, Vol. 15, Núm. 1, pp. 183-194

2012

  1. AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers

    Gene Therapy, Vol. 19, Núm. 4, pp. 411-417

2011

  1. Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice

    Gut, Vol. 60, Núm. 3, pp. 341-349

  2. Self-inactivating helper virus for the production of high-capacity adenoviral vectors

    Gene Therapy, Vol. 18, Núm. 11, pp. 1025-1033

2009

  1. Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters

    Cancer Gene Therapy, Vol. 16, Núm. 9, pp. 703-712

  2. Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy

    Molecular Cancer, Vol. 8

2008

  1. Lethality in an anti-angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1

    Journal of Gene Medicine, Vol. 10, Núm. 10, pp. 1083-1091

2007

  1. Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters

    Human Gene Therapy, Vol. 18, Núm. 8, pp. 681-690

2006

  1. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector

    Cancer Research, Vol. 66, Núm. 3, pp. 1620-1629

2003

  1. Protection against liver damage by cardiotrophin-1: A hepatocyte survival factor up-regulated in the regenerating liver in rats

    Gastroenterology, Vol. 125, Núm. 1, pp. 192-201

2000

  1. Liver damage using suicide genes: A model for oval cell activation

    American Journal of Pathology, Vol. 157, Núm. 2, pp. 549-559